ALHC
Alignment Healthcare, Inc.
NASDAQ · Healthcare · Medical - Healthcare Plans · US
$8.35
−4.02%Sep 16, 2026, 21:33 UTC
Hagens Berman updated its ongoing investigation into Alignment Healthcare on behalf of investors after the company's stock fell nearly 20% following management disclosures at an analyst conference.
Source:Sep 10, 2026, 15:49 UTC
Alignment Health's fifth annual Social Threats to Aging Well in America survey, conducted with Ipsos among more than 2,200 U.S. adults aged 65 and older, found that 90% of seniors report at least one social barrier affecting their health, well-being or access to care, with nearly 70% facing aging-in-place challenges.
Source:Aug 25, 2026, 23:45 UTC
Kaplan Fox & Kilsheimer LLP announced an investigation into potential securities violations by Alignment Healthcare, Inc. following a whistleblower complaint alleging accounting irregularities.
Aug 11, 2026, 08:10 UTC
Alignment Healthcare CEO John Kao sold 298,000 shares of the company's stock on August 10, 2026, at an average price of $13.88, totaling approximately $4.14 million.
Source:Aug 3, 2026, 11:00 UTC
Kaplan Fox & Kilsheimer LLP announced it is investigating potential securities violations by Alignment Healthcare, Inc. and encourages investors who suffered losses to contact the firm.
Jul 30, 2026, 20:01 UTC
Alignment Healthcare reported financial results for the second quarter of 2026, surpassing the high end of guidance across all key metrics.
Jul 28, 2026, 16:55 UTC
Hagens Berman launched an investigation into Alignment Healthcare for potential securities law violations after a whistleblower lawsuit alleged financial manipulation.
Source:Jul 9, 2026, 01:20 UTC
A former Alignment Healthcare executive filed a whistleblower lawsuit alleging the company engaged in deliberate accounting irregularities to inflate its financial results.